Diffuse posterior uveitis Completed Phase 1 Trials for Sirolimus (DB00877)

Also known as: Posterior Uveitis / Chorioretinitis / Uveitis, Posterior / Photoretinitis / Chorioretinitis NOS / Choriodoretinitis / Chorioretinitis, unspecified

IndicationStatusPhase
DBCOND0022016 (Diffuse posterior uveitis)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00908466Sirolimus as Therapeutic Approach to UveitisTreatment